ALP Bio

ALP Bio

Private
LausanneHealthcare & Life Scienceshttps://alpbio.com/

Last Round

Series B

Jul 22, 2021

Total Funding Raised

$100M

Company Overview

ALP Bio is a biotechnology company that develops a novel class of macrocyclic peptides that enhance cellular autophagy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

immunogenicity predictionanti-drug antibodyADAlab-in-the-loopAI drug discoveryantibody engineeringgenerative biologytechbiogenerative biobetter designtonsil organoidAI protein designantibody optimizationin silico screeningbiologics developmentimmune organoidprotein language model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ALP Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ALP Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BJul 22, 2021
Series AJan 1, 2019

ALP Bio Investors

Notable investors and investment history

InvestorRounds
Andreessen HorowitzSeries A, Series B
New Crop CapitalSeries B, Series A
FootPrint Coalition VenturesSeries B
Hillhouse InvestmentSeries B
Germin8 VenturesSeries B, Series A
GL VenturesSeries B
Breakthrough Energy VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 22, 2021

    $75M round led by Andreessen Horowitz and Breakthrough Energy Ventures.

  • Jan 1, 2019

    $25M round with participation from Andreessen Horowitz and AgFunder.

ALP Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ALP Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ALP Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLausanne
Year FoundedN/A
Last FundingJul 22, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.